To The Moon

Log In/Sign Up

freshman1

    • freshman1freshman1
      ·10-09
      Replying to @freshman1:isdfiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfiojsdioufhauehgiuasdgiouadjsiougjsdiogjioasdjgioasdhugsdughsaduhgusdagiojfiodgiuasdufgsdifmaiosdgiuasdbgiuasdniognsaodihgiuashgouansdignioaejfiouawenugnawiongiosdfgioasmiognaiowerngouaewngouewangouaewngowaefiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfiojsdioufhauehgiuasdgiouadjsiougjsdiogjioasdjgioasdhugsdughsaduhgusdagiojfiodgiuasdufgsdifmaiosdgiuasdbgiuasdniognsaodihgiuashgouansdignioaejfiouawenugnawiongiosdfgioasmiognaiowerngouaewngouewangouaewngowaeisdfiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfiojsdioufhauehgiuasdgiouasozhsngiejsle//@freshman1:isdfiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfioj
      @freshman1：
      cool！
      cool！
      8Comment
      Report
    • freshman1freshman1
      ·10-09
      isdfiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfiojsdioufhauehgiuasdgiouadjsiougjsdiogjioasdjgioasdhugsdughsaduhgusdagiojfiodgiuasdufgsdifmaiosdgiuasdbgiuasdniognsaodihgiuashgouansdignioaejfiouawenugnawiongiosdfgioasmiognaiowerngouaewngouewangouaewngowaefiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfiojsdioufhauehgiuasdgiouadjsiougjsdiogjioasdjgioasdhugsdughsaduhgusdagiojfiodgiuasdufgsdifmaiosdgiuasdbgiuasdniognsaodihgiuashgouansdignioaejfiouawenugnawiongiosdfgioasmiognaiowerngouaewngouewangouaewngowaeisdfiohsadhfgiosdaniogsahgaejifhasduhguasiofjadsijfiojsdioufhauehgiuasdgiouasozhsngiejsle//@freshman1:cool！
      @freshman1：
      cool！
      cool！
      64Comment
      Report
    • freshman1freshman1
      ·10-09
      congratulations！
      @Shernice軒嬣 2000：
      $TCOM 20250117 70.0 CALL$ $Trip.com Group Limited(TCOM)$ $TRIP.COM-S(09961)$ I could start thinking about applying for a Prime BTO.
      $TCOM 20250117 70.0 CALL$ $Trip.com Group Limited(TCOM)$ $TRIP.COM-S(09961)$ I could start thinking about applying for a Prime BTO.
      9Comment
      Report
    • freshman1freshman1
      ·10-09
      Replying to @freshman1:reply second repost//@freshman1:second repost//@freshman1:fiest repost
      @freshman1：
      cool！
      cool！
      1631
      Report
    • freshman1freshman1
      ·10-09
      Replying to @freshman1:second repost//@freshman1:fiest repost
      @freshman1：
      cool！
      cool！
      15Comment
      Report
    • freshman1freshman1
      ·10-09
      fiest repost//@freshman1:cool！
      @freshman1：
      cool！
      cool！
      9Comment
      Report
    • freshman1freshman1
      ·10-09
      cool！

      盘前异动 | 百济神州逆市涨超2%， 替雷利珠单抗在美国正式上市

      本周三（10月9日），在中概股普遍大跌的背景下， $百济神州(BGNE)$ 美股盘前逆市涨超2%，截至发稿报240.9美元，涨幅2.32%。公司港股一度涨超8%，最终收涨3.8%。消息面上，百济神州的TEVIMBRA(替雷利珠单抗，中文商品名：百泽安)近日在美国正式商业化上市，用于治疗既往接受过系统化疗(不含PD-1/L1抑制剂)后不可切除或转移性食管鳞状细胞癌(ESCC)的成人患者。据悉，FDA目前还在对TEVIMBRA用于局部晚期不可切除或转移性ESCC患者的一线治疗，以及用于局部晚期不可切除或转移性胃或胃食管结合部(G/GEJ)腺癌患者的一线治疗进行审评。
      盘前异动 | 百济神州逆市涨超2%， 替雷利珠单抗在美国正式上市
      442
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed

       
       
       
       
       

      Terms and Conditions·Privacy Policy

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email：uservice@ttm.financial